Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth
Open accessThe DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Vascular endothelial growth factor (VEGF) is a potent endothelial cell mitogen which mediates its effects by binding to tyrosine kinase receptors. We have characterized the VEGF-activated intracellular signal transduction pathway in bovine aortic endothelial cells and correlated this to its mitogenic effects. VEGF induced concentration- and time-dependent increases in protein kinase C (PKC) activation with a maximum of 2.2-fold above the basal level at 5 x 10(-10) M within 10 min as measured both by in situ and translocation assays. Immunoblotting analysis of PKC isoforms in cytosolic and membrane fractions indicated that after VEGF stimulation the content of Ca(2+)-sensitive PKC isoforms (alpha and betaII) was increased in the membrane fractions, whereas no changes were observed for PKC isoforms delta and epsilon. The stimulation of PKC activity by VEGF was preceded by the activation of phospholipase Cgamma (PLCgamma). This was demonstrated by parallel increases in PLCgamma tyrosine phosphorylation, [3H]inositol phosphate production, and [3H]arachidonic acid-labeled diacylglycerol formation in bovine aortic endothelial cells. In addition, VEGF increased phosphatidylinositol 3-kinase activity 2.1-fold which was inhibited by wortmannin, a phosphatidylinositol 3-kinase inhibitor, without decreasing the VEGF-induced increase in PKC activity or endothelial cell growth. Interestingly, genistein, a tyrosine kinase inhibitor, and GFX or H-7, PKC inhibitors, abolished both VEGF-induced PKC activation and endothelial cell proliferation. VEGF's mitogenic effect was inhibited by a PKC isoform beta-selective inhibitor, LY333531, in a concentration-dependent manner. In contrast, antisense PKC-alpha oligonucleotides enhanced VEGF-stimulated cell growth with a simultaneous decrease of 70% in PKC-alpha protein content. Thus, VEGF appears to mediate its mitogenic effects partly through the activation of the PLCgamma and PKC pathway, involving predominately PKC-beta isoform activation in endothelial cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, within the TME, PKC beta, another PKC isoform, is a well‐documented effector of the VEGF signaling that promotes angiogenesis and is required for invasiveness in certain tumors, such as pancreatic tumors [122, 123, 124].”
From Tumor microenvironment signaling and therapeutics in cancer progression (2023) · cites this paper as [122]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · cited 2×
“and assayed by the method of Bradford (19).”
MethodInfluentialA RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751 · cited 1×
“The cells were scraped and total lipids were extracted with chloroform according to the methods of Bligh and Dyer (22).”
MethodVascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986 · cited 2×
“VEGF was independently isolated as both an endothelial cell growth factor (1) and as a vasopermeability factor (3).”
BackgroundVascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Intracellular Signaling by Hydrolysis of Phospholipids and Activation of Protein Kinase C
Nishizuka, Y. (1992) · Science · doi:10.1126/science.1411571 · Cited by 4,472 · cited 4×
“In contrast, PKC isoforms e and d, which lack Ca(21) binding sites, are only responsive to DAG and did not translocate adequately for our antibodies to detect (25).”
BackgroundMethodInfluentialAiello, L. P., Avery, R. L., Arrigg, P. G., Keyt, B. A., Jampel, H. D., Shah, S. T., Pasquale, L. R., Thieme, H., Iwamoto, M. A., Park, J. E., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199412013312203 · Cited by 3,793 · cited 2×
“Physiologically, elevated levels of VEGF have been associated with tumor angiogenesis (7) and hypoxia-induced proliferative ocular disorders such as diabetic proliferative retinopathy and retinal vein occlusion (8, 9).”
BackgroundSelf-citationGenistein, a specific inhibitor of tyrosine-specific protein kinases.
Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H., Watanabe, S., Itoh, N., Shibuya, M., & Fukami, Y. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)45614-1 · Cited by 3,724 · cited 1×
“The addition of genistein (40 mm), a tyrosine kinase inhibitor (27), significantly reduced the VEGF-induced tyrosine phosphorylation of PLCg.”
BackgroundOncogenes and signal transduction
Cantley, L. C., Auger, K. R., Carpenter, C., Duckworth, B., Graziani, A., Kapeller, R., & Soltoff, S. (1991) · Cell · doi:10.1016/0092-8674(91)90639-g · Cited by 2,694 · cited 2×
“Since PI 3-kinase has been shown to be associated with several different tyrosine kinase receptors (29), and VEGF has been reported to increase PI 3-kinase tyrosine phosphorylation (12, 13), we determined whether PI 3-kinase activity could also be activated by VEGF.”
BackgroundThe bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C
Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., & Loriolle, F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98476-0 · Cited by 2,456
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275 · cited 1×
“Physiologically, elevated levels of VEGF have been associated with tumor angiogenesis (7) and hypoxia-induced proliferative ocular disorders such as diabetic proliferative retinopathy and retinal vein occlusion (8, 9).”
Background
Cited by
Items 501–600 of 615
Molecular Regulation of Endothelial Cell Tight Junctions and the Blood-Retinal Barrier
Runkle, E. A., Titchenell, P. M., & Antonetti, D. A. (2011) · Springer eBooks · doi:10.1007/978-1-60761-150-9_8 · Cited by 2
BIOCHEMICAL BASIS AND EMERGING MOLECULAR TARGETS TO TREAT DIABETIC RETINOPATHY
Suchitra, K., & Panda, T. K. (2016) · International Journal of Clinical and Biomedical Research · Cited by 2
A unique protein kinase C‐dependent pathway for tissue factor downregulation in pericytes
Sommerville, L. J., Gorman, K., Snyder, S. A., Monroe, D. M., & Hoffman, M. (2019) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14399 · Cited by 2
Molecular Tools for Metastatic Colorectal Cancer Characterization
Maitra, R., Fogel, E. J., Parakrama, R. Y., & Goel, S. (2020) · Journal of Cellular Immunology · doi:10.33696/immunology.2.067 · Cited by 2
Laud, K., Shabto, U., & Tello, C. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-20797-1_21-1 · Cited by 2
Aldarwesh, A. (2015) · UEA Digital Repository (University of East Anglia) · Cited by 2
Cardiac Cell and Gene Transfer
Metzger, J. M. (2002) · Humana Press eBooks · doi:10.1385/159259350x · Cited by 2
Flavonoids as Inhibitors of Tumor Metastasis
Zhou, J. (2005) · Nutrition and disease prevention · doi:10.1201/9781420026399.ch16 · Cited by 2
Tumor Angiogenesis as a Target for Early Intervention and Cancer Prevention
Li, W. W. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-767-3_40 · Cited by 2
Microvascular Consequences of Obesity and Diabetes
Bohlen, H. G. (2008) · Wiley eBooks · doi:10.1002/cphy.cp020419 · Cited by 2
Polyphenols in apples and their interactions with vascular endothelial cells
Moyle, C. W. A. (2011) · UEA Digital Repository (University of East Anglia) · Cited by 2
Teicher, B. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-035-5_9 · Cited by 2
Apoptosis and cell cycle in endothelial cells
Spyridopoulos, I. (2000) · Basic science for the cardiologist · doi:10.1007/978-0-585-38143-5_10 · Cited by 2
Ashraf, M., Sun, J. K., Silva, P. S., Cavallerano, J. D., & Aiello, L. P. (2023) · Contemporary cardiology · doi:10.1007/978-3-031-13177-6_15 · Cited by 1
Self-citationMicrocirculatory Exchange Physiology and Molecular Mechanisms Controlling Microvascular Permeability
Breslin, J. W., Motawe, Z. Y., & Chang, M. (2025) · Physiology in health and disease · doi:10.1007/978-3-031-99609-2_2 · Cited by 1
Anti-VEGF Therapies for Diseases of the Retina and Choroid
Lu, M., & D’Amico, D. J. (2007) · Humana Press eBooks · doi:10.1007/978-1-59745-047-8_18 · Cited by 1
Merajver, S. D., Rosenthal, D. T., & Wassenhove, L. D. V. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-543-9_17 · Cited by 1
“perhaps due in part to lower PKCd expression, as well as decreased cell–cell adhesion ( Williams and Noti 2001 ).”
BackgroundSEVERITY OF DIABETIC RETINOPATHY IN RELATION WITH HEMOGLOBIN A1c AND SERUM LIPIDS
Qureshi, T. S., Maqbool, R., Abdullah, N., Ramzan, R., & Fazili, A. B. (2013) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/495 · Cited by 1
“However, studies done by Xia P et al (16) and Miller JW et al (17) have shown no significant benefits of renal protective drugs upon the progression of diabetic retinopathy.”
ResultRoles of PKC Isoforms in Development of Diabetes-Induced Cardiovascular Complications
Özakça, I., & Ozcelikay, A. T. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9317-4_16 · Cited by 1
Laud, K., & Shabto, U. (2009) · Springer eBooks · doi:10.1007/978-0-387-09841-8_21 · Cited by 1
Doucette, C. D. (2013) · DalSpace (Dalhousie University) · Cited by 1
Diabetische Retinopathie: Krankheitsbild, Diagnostik und Therapiemöglichkeiten
Wahrlich, N., Uibel, S., Klingelhoefer, D., & Groneberg, D. A. (2014) · Zentralblatt für Arbeitsmedizin Arbeitsschutz und Ergonomie · doi:10.1007/s40664-013-0003-3 · Cited by 1
“Es konnte gezeigt werden, dass der PKC-β-Isoform-Inhibitor Ruboxistaurin bei Patienten mit mäßig schwerer bis schwerer NPDR sehr gut toleriert wurde und das Risiko für Sehverluste reduzierte [80].”
Study the Acousto-Optic Spatial Filters Diffracted Light at Zeroth-Order Using MATLAB
Elham, J. M., & Aseel, M. A. (2018) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/454/1/012134 · Cited by 1
Regenerative Medicine and the Diabetic Foot
Stern‐Buchbinder, Z. A., Hajhosseini, B., & Gurtner, G. C. (2020) · Wiley eBooks · doi:10.1002/9781119445821.ch28 · Cited by 1
Laud, K., Shabto, U., & Tello, C. A. (2017) · Springer eBooks · doi:10.1007/978-3-319-18741-9_21 · Cited by 1
Insulin Resistance Is an Alternative, Novel Risk Factor for Diabetes-Associated Periodontitis
Shinjo, T., & Zeze, T. (2023) · Current Oral Health Reports · doi:10.1007/s40496-023-00345-0 · Cited by 1
“LPS and TNFα-induced VCAM1 expression was mainly dependent on both NF-κB and p38 activation, which is consistent with those of other studies showing the involvement of p65 or p38 activation in VCAM-1 expression in macrovascular ECs [46].”
ResultWright, A. F. (2014) · Enlighten: Theses (The University of Glasgow) · Cited by 1
Oncologic, Endocrine & Metabolic Emerging drugs in B-cell non-Hodgkin's lymphoma
Kassam, S., & Montoto, S. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.13.2.323 · Cited by 1
“PKC β is required for B-cell receptor-induced activation of NFκ B [69] and is involved in vascular endothelial growth factor signalling in the tumour microvasculature [70] .”
BackgroundVEGFR-3 Ligands and Lymphangiogenesis
Jeltsch, M. (2002) · Työväentutkimus Vuosikirja · Cited by 1
Signalling pathways downstream of vascular endothelial growth factor receptors
KNIGHT, E. L. (2001) · Figshare · Cited by 1
Contribuições para a Avaliação Clínica do Edema Macular Diabético
Pires, I. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Voabil, P. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · Cited by 1
Impact du VEGF sur les altérations synaptiques dans la maladie d’Alzheimer
Martin, L. (2018) · theses.fr (ABES) · doi:10.70675/e24b560ez70e5z4840z9195zde9043132aa0 · Cited by 1
Huminiecki, L., Bicknell, R., Singh, J. P., Mendelsohn, L. G., Badet, J., & Cuevas, P. (2000) · Springer eBooks · doi:10.1007/978-3-642-57063-6_1 · Cited by 1
The Role of Protein Kinase C Activation in the Development of Diabetic Vascular Complications
King, G. L. (1998) · Endocrine updates · doi:10.1007/978-1-4615-5569-8_10 · Cited by 1
Self-citationNovel Therapeutic Strategies For Posterior Segment Neovascularization
Bingaman, D. P., Gu, X., Timmers, A. M., & Davis, A. A. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6780-8_23
Palettas, M. S. (2013) · The Knowledge Bank (The Ohio State University)
The Role of Protein Kinase C β (PKCβ) in Breast Cancer
Sharma, N. (2013) · The Knowledge Bank (The Ohio State University)
Epineural Patch Applications in Dorsal Root Ganglion Decompression Model
Siemionow, K. B. (2014) · Springer eBooks · doi:10.1007/978-1-4471-6335-0_61
Joo, B., & Hun, J. (2012) · InTech eBooks · doi:10.5772/31042
Angiogenesis in diabetic retinopathy: a history of accomplishment, discovery and promise
Aiello, L. P. (1998) · Springer eBooks · doi:10.1007/978-94-011-4962-4_12
Self-citationClinical Trials in Protein Kinase C-β Inhibition in Diabetic Retinopathy
Sun, J. K., Hamam, R. N., & Aiello, L. P. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-563-3_18
Self-citationEffect of Drugs on Rabbit Retina
Myers, A. C. (2013) · Lund University Publications (Lund University)
The Role of Protein Kinase C in Diabetic Retinal Vascular Abnormalities
Sun, J. K., & King, G. L. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6780-8_10
Self-citationMartín, C., & del Pilar, M. (2003) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona)
Effect of Bevacizumab and Ranibizumab on the Expression of eNOS in Trabecular Meshwork Cells
Kim, S. E., & Kim, J. W. (2014) · Journal of the Korean Ophthalmological Society · doi:10.3341/jkos.2014.55.8.1208
Huang, L. (2010) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1857
New Insights into the Molecular Mechanisms of Vascular Permeability in Diabetes
Antonetti, D. A. (2002) · Springer eBooks · doi:10.1007/978-94-010-0614-9_3
Vascular Complications in Diabetes
Dunn, L., Chan, K. H., Ng, M., & Stocker, R. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1428-5_15
Use of Animal Models to Evaluate Signal Transduction Inhibitors As Modulators of Cytotoxic Therapy
Teicher, B. A. (2005) · Humana Press eBooks · doi:10.1385/1-59259-864-1:231
Emerging drugs in B-cell non-Hodgkin's lymphoma
Kassam, S., & Montoto, S. (2008) · Expert Opinion on Emerging Drugs · doi:10.1517/14728210802002780
Vascular endothelial growth factor
Loughran, J. H., Birks, E. J., & Bolli, R. (2013)
Diabetic Retinopathy: The Need for Predictive, Preventive and Personalized Approach to Management
Josifova, T., & Henrich, P. B. (2013) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-007-5971-8_8
Effects of VEGFR-2 signalling in post-natal hematopoiesis and vasculogenesis
Larrivée, B. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0092380
“, 1986), as well as some megakaryocytes (Xu et al., 2001) and primitive macrophages (Shepard and Zon, 2000), as opposed to definitive hematopoiesis, which can generate mature cells of all the blood lineages.”
BackgroundREGULATION OF ACTIVATION PHASE OF ANGIOGENESIS BY TRANCRIPTION FACTORS ETS1 AND ETS2
Ghosh, S. (2014) · OhioLink ETD Center (Ohio Library and Information Network)
Épidémiologie et physiopathologie de la rétinopathie diabétique
Massin, P., & Pâques, M. (2004) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(04)74280-8
Pathogenesis and treatment of diabetic retinopathy
Hayakawa, M. (1997) · Juntendō Igaku/Juntendo igaku · doi:10.14789/pjmj.43.393
Chapter 4. Diabetic Retinopathy
Murphy, J., & Rahhal, F. M. (2004)
Signalling via vascular endothelial growth factor receptor complexes
Roberts, S. K. (2005) · OpenGrey (Institut de l'Information Scientifique et Technique)
Expression and localization of mRNA for the VEGF system and FP receptor in porcine corpora lutea.
Boonyaprakob, U. (2002) · NCSU Libraries Repository (North Carolina State University Libraries)
Estudio de la función de la familia de Proteínas Quinasas C en el cáncer de mama
Nicolás, R. L. (2011) · Tesis Doctorals en Xarxa (Consorci de Serveis Universitaris de Catalunya)
Novel approaches to the treatment of diabetic nephropathy
Langham, R. G., Kelly, D. J., & Gilbert, R. E. (2003) · CRC Press eBooks · doi:10.3109/9780203502976-16
Werdich, X. Q. (2005) · Europe PMC (PubMed Central)
Analysis of the VEGFR1 (FLT-1) Isoforms in Vascular Development
Kappas, N. C. (2006) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/b1ya-7d17
The regulation of integrin vesicular trafficking
Roberts, M. S. (2002) · Figshare
Mason, J. C., Lidington, E. A., Ahmad, S. R., & Haskard, D. O. (2001)
Implication de la Protéine Tyrosine Phosphatase PRL-2 dans le développement vasculaire
Poulet, M. (2017) · theses.fr (ABES) · doi:10.70675/ed451ac7zcce3z48e6zbc9ez79bc6299cf3f
Activités proinflammatoires des angiopoïétines
Lemieux, C. (2004) · doi:10.71781/31881
The effects of green tea and pomegranate polyphenols on in vitro and in vivo VEGF activity
Edwards, R. L. (2016) · UEA Digital Repository (University of East Anglia)
Investigating Endothelial Dysfunction in a CRISPR/Cas9 Model of Fabry Disease
Kaissarian, N. M. (2017) · Deep Blue (University of Michigan)
Queiroz, M. S. (2016) · Diabetes & Metabolic Disorders · doi:10.24966/dmd-201x/100008
“Increased levels of inflammation and endothelial dysfunction markers such as C-Reactive Protein (CRP), Fibrinogen (FIB), Interleukin-6 (IL-6), Tumor Necrosis Factor-alpha (TNF-α), Vascular Endothelial Growth Factors (VEGF), Growth Hormone, Insulin-like Growth Factor-I (IGF-I), Transforming Growth Factor-β (TGF-β), sol…”
Src family kinase interactions with the vascular endothelial growth factor receptors
Chou, M. T.-H. (2003) · Libraries and Cultural Resources (University of Calgary) · doi:10.11575/prism/16972
Bayko, L. (1997) · TSpace (University of Toronto)
Retinopatia diabética: mecanismos básicos y avances terapéuticos
Bravo, G. B., Flumian, C., Gómez, M. C., & Levy, G. V. (2010) · Americanae (AECID Library)
Investigation of Flt1 and VEGF signaling in connections during sprouting angiogenesis
Nesmith, J. E. (2016) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/k2av-er67
Asthana, M. (2019) · edoc (University of Basel) · doi:10.5451/unibas-007168930
Stewart, L. (2019) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Kinnunen, K. (2009) · UEF eRepo (University of Eastern Finland)
VanGilder, R. L. (2009) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.4544
Chanchal, N., Goyal, K., Vij, D., & Mishra, R. K. (2021) · International Ayurvedic Medical Journal · doi:10.46607/iamj1709072021
(2006) · Wiley eBooks · doi:10.1002/9780470041000.cedt023
Murphy, J., & Rahhal, F. M. (2004) · Springer eBooks · doi:10.1007/978-1-4757-6260-0_18
Éléments de physiopathogénie de la rétinopathie diabétique
(2010) · Elsevier eBooks · doi:10.1016/b978-2-294-61171-1.50002-7
Cyclic peptides targeting pathological angiogenesis
Ye, X. (2023) · theses.fr (ABES) · doi:10.70675/8404071ez9a5ez4b69za47dzfc75b6925932
Aiello, L. P., & Cavallerano, J. D. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-091-9_21
Self-citationKAMALESH, D. R., & Geetha, K. (2025) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2025.100266
Éléments de physiopathogénie de la rétinopathie diabétique
Massin, P., Dupas, B., Erginay, A., Feldman, S., & Lecleire-Collet, A. (2025) · Elsevier eBooks · doi:10.1016/b978-2-294-78350-0.00002-7
Regulation of Angiogenesis Via VEGF/Thrombospondin-1 Signaling
Watnick, R. S. (2025) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-031-93894-8_5
Microcirculatory Exchange Function
Durán, W. N., Sánchez, F. A., & Breslin, J. W. (1984) · Comprehensive physiology · doi:10.1002/j.2040-4603.1984.tb01013.x
Microvascular Consequences of Obesity and Diabetes
Bohlen, H. G. (1984) · Comprehensive physiology · doi:10.1002/j.2040-4603.1984.tb01028.x
A STUDY OF THE MOLECULAR GENETICS OF RENAL CELL CARCINOMA IN MAN
Ollerenshaw, M. (2003) · PEARL (University of Plymouth) · doi:10.24382/4230
Diabetic Macular Edema Management
บวรวัฒนดิลก, ไ. (n.d.) · Eye South East Asia · doi:10.14456/ttjo.2007.9
Metadata
- Authors
- Xia, P., Aiello, L. P., Ishii, H., Jiang, Z. Y., Park, D. J., Robinson, G. S., Takagi, H., Newsome, W. P., Jirousek, M. R., & King, G. L.
- Affiliations
- Joslin Diabetes Center (US)
- Brigham and Women's Hospital (US)
- Harvard University (US)
- Eli Lilly (United States) (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1996-11-01
- Volume
- 98
- Issue
- 9
- Pages
- 2018-2026
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC507645
- OpenAlex
- W2075553837
- Cited by
- 566
- References
- 39
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 5 · 2023: 6 · 2022: 5 · 2021: 6 · 2020: 7 · 2019: 8 · 2018: 3 · 2017: 3 · 2016: 9 · 2015: 8 · 2014: 14 · 2013: 21 · 2012: 19
- FWCI
- 8.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health (5r01dk036433-10, 5r29ey010827-04, 5r01ey005110-18, EY05110)
- National Eye Institute (EY10827, EY05110)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK36433)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Keywords
- vascular endothelial growth factor, protein kinase C, PKC isoforms, PKC beta, endothelial cell proliferation, signal transduction, phospholipase C-gamma, phosphatidylinositol 3-kinase, diacylglycerol, ruboxistaurin, genistein, wortmannin, bovine aortic endothelial cells
- MeSH terms
- Animals, Cattle, Cell Division, Diglycerides, Endothelium, Vascular, Enzyme Activation, Inositol Phosphates, Isoenzymes, Lymphokines, Type C Phospholipases, Protein Kinase C, Signal Transduction, Endothelial Growth Factors, DNA, Antisense, Phosphotransferases (Alcohol Group Acceptor), Phosphotyrosine, Phosphatidylinositol 3-Kinases, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Phospholipase C gamma
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.